SecBot SecBot
Insider Buy ·Filed Jun 16, 2026

ARTV

Artiva Biotherapeutics, Inc.
BULLISH
Impact 7/10
Horizondays Processed5mo ago SEC0001231919-26-000656
Insider cluster: 1 insiders, $11.1M total
Actionable Insight ▲ Bullish

This is a massive insider buy from a major shareholder that should be read as a strong bullish signal. Traders should monitor for upcoming catalysts such as clinical trial updates or partnership announcements.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$9.94
T+0 close · Jun 16, 2026 · via day close
Latest settled
+2.01%
T+60 · $10.14
Vs SPY
−0.68%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 17 $9.94entry
  2. T+1 · 5mo ago −1.21%α −1.99% · $9.82
  3. T+5 · 5mo ago −6.24%α −5.20% · $9.32
  4. T+20 · 4mo ago −9.05%α −10.37% · $9.04
  5. T+60 · 2mo ago +2.01%α −0.68% · $10.14
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RA Capital Management, a director and 10% owner, purchased 1.43 million shares of Artiva Biotherapeutics for $11.14 million across five open-market trades from June 9-12, 2026. The purchase represents approximately 4.9% of the company's $227 million market cap, a highly material insider buying signal that indicates strong conviction in the company's prospects.

Key Financial Metrics

Direction
buying
Total Value
$11.1M
Insiders
1

Key Facts

  • Total insider purchase of $11.14 million over 5 trades from June 9-12, 2026
  • Purchase represents ~4.9% of $227M market cap, well above the 2% materiality threshold
  • Only insider is RA Capital Management, L.P., acting as both director and 10% owner
  • Prices ranged from $6.91 to $8.99 per share, with largest trades at higher prices
  • Recent 30-day insider activity shows $12.3M in total buys vs $450K in sells, indicating net accumulation

Financial Impact

$11.14 million purchase, approximately 4.9% of market cap

float reductioninsider ownership increasemarket cap

Risk Factors

  • Biotech single-product risk and clinical-stage volatility
  • Insider could be buying to maintain ownership percentage ahead of dilution or strategic move

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001231919-26-000656

Track record

33 reports on ARTV

Performance horizon

11 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 5h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026